Karin Sundfeldt

ORCID: 0000-0002-7135-3132 · 30 papers in corpus
other 2017
BMC cancer ·doi:10.1186/s12885-017-3289-2

BACKGROUND: To characterize the expression of the membrane transporter NaPi2b and antigen targeted by the MX35 antibody in ovarian tumor samples. The current interest to develop monoclonal antibody based therapy of ovarian cancer by targeti…

other 2015
PloS one ·doi:10.1371/journal.pone.0130197

BACKGROUND: Mucins are heavily O-glycosylated proteins where the glycosylation has been shown to play an important role in cancer. Normal epithelial ovarian cells do not express secreted mucins, but their abnormal expression has previously …

other 2014
Cancer medicine ·doi:10.1002/cam4.282

Mortality rates for epithelial ovarian cancer (EOC) are high, mainly due to late-stage diagnosis. The identification of biomarkers for this cancer could contribute to earlier diagnosis and increased survival rates. Given that chronic inflam…

other 2012
Clinical proteomics ·doi:10.1186/1559-0275-9-14

BACKGROUND: We aimed to investigate the use of ovarian cyst fluid as a source for biomarker discovery and to find novel biomarkers for use in the diagnosis of epithelial ovarian tumors. RESULTS: Ovarian cyst fluids from 218 women were coll…

other 2006
Molecular cancer ·doi:10.1186/1476-4598-5-62

BACKGROUND: The involvement of the cyclooxygenases (COX), in particular COX-2, is well documented for many tumours, e.g. colon, breast and prostate cancer, by both experimental and clinical studies. There are epidemiological data from subje…